Cellromax Science Revenue

Cellromax Science had revenue of 5.09B KRW in the quarter ending June 30, 2026, a decrease of -21.24%. This brings the company's total for the last twelve months to 19.60B, down -16.01% year-over-year. In the year 2025, Cellromax Science had annual revenue of 22.18B with 2.56% growth. That makes Cellromax Science the 35,524th largest company in the world by revenue and 2,265th in South Korea.

Revenue (ttm)

19.60B

Revenue Growth

-16.01%

P/S Ratio

2.23

Revenue / Employee

455.91M

Employees

Market Cap

44.32B

Revenue Chart

Chart

Revenue by Segment

By Segment

Chart

Health Food Division 18.96B 85.5%
Cosmetics Division 1.35B 6.1%
Other 940.70M 4.2%
General Pharmaceuticals Division 937.36M 4.2%

By Geography

Chart

Korea 22.13B 99.8%
Asia 53.40M 0.2%

Fiscal year ended Dec 31, 2025 See the full Cellromax Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	22.18B	553.61M	2.56%
Dec 31, 2024	21.63B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.